International Association of Hepatitis Task Forces
@IAHTF
National Association of Hepatitis Task Forces (NAHTF) is expanding internationally to better support, serve & advocate for the hepatitis community worldwide.
Obesity treatment is healthcare. Expanding access to GLP-1 medications through Medi-Cal could help prevent diabetes, heart disease, and other costly chronic conditions while improving the quality of life for California patients.
Read more here: https://t.co/tljswQCwog
#ICYMI: Tomorrow the @LiverCoalition is hosting an important conversation on MASLD and MASH. Learn from healthcare experts, advocates, and gain valuable insights into liver health, obesity care, public health, and patient experiences.
Register here: https://t.co/VRJMMfwS2r
#Wisconsin has launched a new initiative aimed at eliminating #hepatitis by 2030. The plan focuses on expanding statewide access to testing, vaccination, and treatments to reduce hepatitis-related illness and deaths.
Read more here: https://t.co/4w1IQJNkcX
The U.S. is missing a key chance to fight hepatitis C—drug treatment centers. England shows that integrated care in these settings can boost testing, treatment, and save lives.
Read more here: https://t.co/6OH7Mikoii
A @nature study found that people with severe mental disorders face higher #hepatitisC risk and lower treatment adherence. The study suggested that nurse navigation programs may help improve care coordination and support access to treatment.
https://t.co/2CtvIED16T
.@SenateGOP@SenateDems reject #MFN drug pricing policies that would have devastating consequences to #patients living w/ #hepatitis & other chronic diseases. America should be leading the way, not following European models that delay & restrict access to life saving treatments.
May is #HepatitisAwarenessMonth! Despite setbacks in federal support for evidence-based prevention strategies, including childhood immunization, we remain focused on advancing disease elimination through expanded access to prevention, testing, and care.
.@CAGovernor, we urge you to restore GLP-1 coverage under Medi-Cal to ensure Californians living with obesity have access to critical treatment options. Cutting GLP-1 coverage prioritizes short-term budget savings over long-term health outcomes.
https://t.co/faIZpNyjM0
A new study analyzed global efforts to meet the @WHO 2030 hepatitis C elimination goal, revealing disparities in care for men with same sex partners and lower-income countries.
Read more here: https://t.co/8fEBNejQi3
Digital tools and tailored #HIV services delivered by community health workers in rural #Kenya and #Uganda reduced new cases by 70%.
Read more here: https://t.co/Y4URJtgkMc
A new blood test, FAP-Index, may help identify serious liver scarring in people with metabolic dysfunction-associated steatotic liver disease #MASLD.
Read more here: https://t.co/7IXNMmGJPB
Vaccinating newborns against #hepB protects about 95% of those who complete the full vaccine series, offering lifelong immunity.
Read more here: https://t.co/n1ySGQ1yyI
A new study from #EastGodavari highlights the overlooked reality of #T2D, with women experiencing the highest levels of emotional burden.
Read more here: https://t.co/vTutTA3s4D
The CDC’s change to “shared decision-making” for essential childhood vaccines, including #hepatitisA, risks access to preventive care.
Read more here: https://t.co/3WMnMn5v1U
#Florida changes its eligibility requirements for the AIDS Drug Assistance Program, putting 15,000 people living with #HIV at risk of affordable medication access.
Read more here: https://t.co/kVkcvqCx0s
The House has recently approved a three-year extension of enhanced ACA premium tax credits, keeping more Americans covered and sending the bill to the Senate for negotiations.
Read more here: https://t.co/nesAfSHVY1
A #hepatitisA outbreak in eastern Santiago de Cuba is threatening public health, with officials calling for intensified preventive measures and disease management.
Read more here: https://t.co/HsUG5XSHjN
New research from Keio University School of Medicine shows promising advances in liver disease, with scientists achieving record-breaking growth in miniature, functional liver models.
Read more here: https://t.co/BTeltHaEAa